United States

Tinnitus in the United States: 50 Million Americans, VA Claims & Treatment Access

15 min readLast updated April 2026Reviewed by audiology professionals

The Scale of Tinnitus in America

Tinnitus affects an enormous number of Americans, though the exact figure depends on the definition and methodology used. The most commonly cited estimates, drawn from data published by the Hearing Health Foundation (HHF), the National Institute on Deafness and Other Communication Disorders (NIDCD), and AARP, suggest that 25 to 50 million Americans experience some form of tinnitus. Of these, approximately 20 million have chronic tinnitus that is bothersome enough to seek medical attention, and roughly 2 million experience tinnitus so severe that it is debilitating.

The Centers for Disease Control and Prevention (CDC) has reported that approximately 15 percent of the general adult population in the United States experiences some form of tinnitus, with prevalence increasing with age. Among adults aged 65 to 74, the prevalence rises to approximately 25 to 30 percent. Men are more likely to experience tinnitus than women, a disparity largely attributed to higher rates of occupational and recreational noise exposure among men, particularly in military service, construction, manufacturing, and motorsports.

Racially and socioeconomically, tinnitus does not discriminate, but access to treatment does. Data from the National Health Interview Survey (NHIS) indicates that non-Hispanic white Americans report tinnitus at slightly higher rates than other groups, though this may reflect differences in healthcare access and reporting rather than true prevalence differences. Hispanic Americans and African Americans with tinnitus are significantly less likely to have accessed audiological services, highlighting disparities in the US healthcare system.

The economic burden of tinnitus in the United States is staggering. Research published in the American Journal of Preventive Medicine estimated that tinnitus costs the US healthcare system approximately 26 billion dollars annually in direct medical costs. When indirect costs including lost productivity, absenteeism, and disability payments are included, the total economic impact exceeds 56 billion dollars per year, making tinnitus one of the most expensive chronic conditions in America.

πŸ‡ΊπŸ‡Έ

Between 25 and 50 million Americans experience tinnitus, with annual economic costs exceeding $56 billion when combining direct and indirect expenses

Tinnitus as the Number One VA Disability Claim

Tinnitus holds a unique and significant position in the United States as the number one service-connected disability among military veterans. According to the Department of Veterans Affairs (VA), tinnitus has been the most prevalent service-connected disability every year for over two decades, with more than 2.5 million veterans receiving compensation for tinnitus as of fiscal year 2025.

The reasons for the extraordinarily high prevalence of tinnitus among veterans are well documented. Military service exposes personnel to sustained and impulse noise levels far exceeding safe thresholds. Weapons fire, explosions, aircraft engines, shipboard machinery, and armoured vehicle noise create cumulative damage to the auditory system. Research from the VA's National Center for Rehabilitative Auditory Research (NCRAR) in Portland, Oregon, has found that veterans who served in combat zones have tinnitus prevalence rates approximately three times higher than the general population.

The VA rates tinnitus as a service-connected disability using its Schedule for Rating Disabilities. The maximum rating for tinnitus alone is 10 percent, which translates to a monthly compensation payment. While 10 percent may seem modest, tinnitus is frequently rated alongside hearing loss and other conditions, and the cumulative disability rating can be substantial. A veteran with tinnitus (10 percent), bilateral hearing loss (potentially 0 to 100 percent depending on severity), and post-traumatic stress disorder (potentially 10 to 100 percent) can receive significant combined compensation.

Filing a VA disability claim for tinnitus requires establishing a nexus between military service and the condition. Veterans need service medical records, a current diagnosis, and a medical opinion linking the two. The VA provides audiology examinations at VA Medical Centers and Community-Based Outpatient Clinics (CBOCs) as part of the claims process. Veterans Service Organizations (VSOs) such as the American Legion, Veterans of Foreign Wars (VFW), and Disabled American Veterans (DAV) provide free assistance with claims filing.

Lushh delivers clinically-informed sound therapy and CBT-based management techniques that complement VA tinnitus services. Try it free for 7 days β†’

Treatment Options and Insurance Coverage in the US

The American healthcare landscape for tinnitus treatment is complex, fragmented, and heavily dependent on insurance coverage. Unlike countries with universal healthcare systems, Americans face significant variations in treatment access based on their insurance status, geographic location, and financial resources.

Private Health Insurance

Most private health insurance plans cover the diagnostic evaluation of tinnitus, including ENT consultations and audiometric testing. However, coverage for ongoing tinnitus management varies widely. Many insurance plans classify tinnitus management as hearing-related and apply exclusions similar to those for hearing aids. As of 2026, only a handful of states mandate hearing aid coverage for adults, though this number has been growing.

Cognitive behavioural therapy for tinnitus is typically covered under mental health benefits, thanks to the Mental Health Parity and Addiction Equity Act. However, finding a therapist who specialises in CBT for tinnitus can be challenging, and patients may need to use out-of-network benefits at higher out-of-pocket cost. Sound therapy devices, when not classified as hearing aids, are generally not covered by insurance.

Medicare and Medicaid

Medicare currently provides limited coverage for tinnitus services. Part B covers diagnostic audiology services when ordered by a physician, but traditional Medicare does not cover hearing aids or routine hearing examinations. This creates a significant gap for the large population of Medicare-eligible seniors with tinnitus, as hearing aids with tinnitus management features are among the most effective interventions. The Hearing Aid Tax Credit proposals and various legislative initiatives have attempted to address this gap, with varying degrees of progress.

Medicaid coverage for tinnitus varies by state, with some states providing hearing aid benefits and others offering minimal audiological coverage beyond diagnostic testing. The expansion of Medicaid under the Affordable Care Act has improved access for low-income Americans in participating states, but coverage gaps persist.

Over-the-Counter Hearing Aids

The FDA's 2022 rule establishing over-the-counter (OTC) hearing aids has created new, more affordable options for Americans with mild to moderate hearing loss and tinnitus. OTC devices from manufacturers such as Jabra, Sony, and Lexie are available at prices between 500 and 1,500 dollars, significantly less than prescription hearing aids which average 4,000 to 6,000 dollars per pair. Several OTC hearing aids include tinnitus masking features, providing combined amplification and sound therapy in an accessible package.

🎧

Clinically-informed tinnitus relief without insurance barriers or $4,000 devices

Download Lushh β€” Free β†’

Lenire, Neuromodulation, and Emerging Treatments

The United States has seen a surge of interest in neuromodulation-based tinnitus treatments, led by the FDA clearance of the Lenire device by Neuromod Devices in 2023. Lenire uses bimodal neuromodulation, combining electrical stimulation of the tongue with precisely timed sound stimulation delivered through headphones, to drive neuroplastic changes in the brain's auditory processing networks.

The clinical evidence for Lenire comes primarily from the TENT-A1, TENT-A2, and TENT-A3 clinical trials, which demonstrated statistically significant reductions in tinnitus severity in approximately 80 percent of participants who completed the 12-week treatment protocol. The device received FDA De Novo clearance as the first neuromodulation device specifically indicated for tinnitus treatment in the United States.

However, Lenire comes with a significant price tag. The device costs approximately 4,000 dollars, plus the cost of initial audiological assessment and fitting appointments. Insurance coverage is limited, with most private insurers and Medicare classifying it as investigational or experimental. This puts Lenire out of reach for many Americans with tinnitus, particularly given that it is not a cure but a treatment that reduces symptoms, with some patients requiring maintenance sessions.

For many Americans, app-based alternatives that deliver evidence-based sound therapy and CBT techniques at a fraction of the cost represent a more accessible entry point to tinnitus management. While these tools have different mechanisms of action than bimodal neuromodulation, they address the same cognitive and emotional factors that drive tinnitus distress and have their own evidence base supporting their effectiveness.

The American Tinnitus Association and Support Resources

The American Tinnitus Association (ATA), founded in 1971 and headquartered in Portland, Oregon, is the nation's leading tinnitus advocacy and research organisation. The ATA provides educational resources, funds scientific research through its annual grants programme, and advocates for improved tinnitus healthcare access at the federal and state levels.

The ATA's website serves as a comprehensive information hub, offering resources on tinnitus management, a provider directory, and guides for navigating the healthcare system. Their publications and webinars feature leading tinnitus researchers and clinicians, providing patients with access to the latest evidence and expert guidance. The ATA also facilitates online support communities where patients can connect with others who understand their experience.

Other US Support Resources

US Research and Clinical Trials

The United States is the world's largest funder of tinnitus research, primarily through the National Institutes of Health (NIH), the Department of Defense (DoD), and the VA. Combined federal tinnitus research funding exceeds 50 million dollars annually, supporting studies at institutions across the country.

Key Research Institutions

The VA's National Center for Rehabilitative Auditory Research (NCRAR) in Portland leads military and veteran tinnitus research, with programmes spanning basic science, clinical trials, and rehabilitation outcomes. Their Progressive Tinnitus Management (PTM) programme, a stepped-care model that matches treatment intensity to patient need, has been adopted across the VA system and is being tested in civilian healthcare settings.

The University of Iowa has been a pioneer in direct neural recording studies of tinnitus. Their research, which involves recording electrical activity directly from the auditory cortex of patients undergoing brain surgery, has provided unprecedented insights into how tinnitus is represented in the brain. These findings have implications for developing targeted neuromodulation therapies.

Research at the University of Michigan has focused on the relationship between somatosensory inputs and tinnitus, demonstrating that jaw clenching, neck tension, and other musculoskeletal factors can modulate tinnitus in a significant proportion of patients. This research supports multimodal treatment approaches that address both auditory and somatosensory contributors to tinnitus.

JAMA and New England Journal Studies

Recent high-profile publications in JAMA (Journal of the American Medical Association) and the New England Journal of Medicine have elevated tinnitus's profile in mainstream medicine. A 2024 JAMA systematic review of tinnitus interventions provided clinicians with an evidence-based framework for treatment decisions, concluding that CBT has the strongest evidence, followed by sound therapy, and that combination approaches yield the best outcomes. These publications have helped shift tinnitus from a condition often dismissed by physicians to one recognised as warranting active management.

ADA Workplace Accommodations for Tinnitus

Under the Americans with Disabilities Act (ADA), employees with tinnitus that substantially limits one or more major life activities may be entitled to reasonable workplace accommodations. The ADA's broad definition of disability, expanded by the ADA Amendments Act of 2008, means that significant tinnitus can qualify as a disability even if it is intermittent or managed with treatment.

Common workplace accommodations for tinnitus include quiet workspace assignments or sound-dampening modifications, permission to use sound masking devices or white noise machines, flexible scheduling to accommodate medical appointments and fatigue from sleep disruption, and reduction of exposure to loud workplace noise. Employers with 15 or more employees are required to provide reasonable accommodations unless doing so would create undue hardship.

The Job Accommodation Network (JAN), funded by the US Department of Labor, provides free guidance to both employees and employers on tinnitus accommodations. Their resources include sample accommodation letters, information on assistive technology, and consultation services. JAN reports that tinnitus-related accommodation requests have increased steadily over the past decade, reflecting growing awareness that tinnitus is a legitimate occupational health concern.

Workers who develop tinnitus from occupational noise exposure may also have claims under state workers' compensation systems. Unlike the VA disability system, civilian workers' compensation varies significantly by state in terms of eligibility criteria, benefit levels, and the process for establishing noise-induced tinnitus claims. Consulting with a workers' compensation attorney familiar with hearing loss claims is advisable for workers pursuing this avenue.

With the right combination of professional care, self-management strategies, and workplace accommodations, most Americans with tinnitus can achieve meaningful improvement in their quality of life, even in the absence of a cure.

For the tens of millions of Americans living with tinnitus, the landscape is gradually improving. Federal research investment is at record levels, new treatment technologies are entering the market, and awareness among both clinicians and the public is growing. While systemic challenges around insurance coverage and treatment access persist, evidence-based management approaches are available, and digital health tools are making effective strategies accessible to a broader population than ever before.

Start Managing Your Tinnitus Today

Lushh provides evidence-based sound therapy and CBT techniques, accessible to all Americans regardless of insurance coverage.

Try Lushh Free for 7 Days